Sign in

CIK 0001285819

  • Non-accelerated filer
  • Smaller reporting company

OMEROS CORP

Sign in to watch
Ticker
OMER
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
WA
Entity type
Operating
EIN
911663741
Phone
+1 206-676-5000
Business address
201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale VP Finance and CAO sold 23,792 shares at an average $23.80 ($566,160)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale VP Patent and General Counsel sold 62,528 shares at $21.45 ($1,341,226)
  7. 4 Open-market sale VP Finance and CAO sold 1,020 shares at $22.45 ($22,899)
  8. 4 Exercise or conversion Chairman, CEO & President acquired 142,001 shares (option exercise)
  9. 4 Exercise or conversion VP Patent and General Counsel acquired 8,000 shares (option exercise)
  10. 4 Open-market sale VP Finance and CAO sold 12,000 shares at $24.95 ($299,400)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market sale VP Finance and CAO sold 24,000 shares at an average $21.20 ($508,800)
  18. 4 Open-market sale Director sold 3,000 shares at $16.49 ($49,474)
  19. 4 Exercise or conversion VP Patent and General Counsel acquired 2,040 shares (option exercise)
  20. 4 Derivatives Options or other derivatives

Page 8 of 15 · 295 filings